Outcome of 98 patients with epithelioid sarcoma treated in curative intent: A retrospective study from the French Sarcoma Group (GSF-GETO)

被引:0
|
作者
Pedrono, M. [1 ]
Mir, O. [2 ]
Chaltiel, L. [3 ]
Brahmi, M. [4 ]
Italiano, A. [5 ]
Decanter, G. [6 ]
Rouquette, P. Boudou [7 ]
Ropars, M. [8 ]
Bompas, E. [9 ]
Firmin, N. [10 ]
Isambert, N. [11 ]
Valentin, T. [12 ]
Duffaud, F. [13 ]
Gantzer, J. [14 ]
Thyss, A. [15 ]
Guillemet, C. [16 ]
Blay, J-Y. [4 ]
Le Cesne, A. [2 ]
Chevreau, C. M. [12 ]
Perrin, C. [1 ]
机构
[1] Ctr Eugene Marquis, Med Oncol, Rennes, France
[2] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[3] Inst Univ Canc Toulouse IUCT Oncopole, Biostat Unit, Inst Claudius Regaud, Toulouse, France
[4] Ctr Leon Berard, Med Oncol, Lyon, France
[5] Inst Bergonie, Med Oncol, Bordeaux, France
[6] Ctr Oscar Lambret, Surg, Lille, France
[7] Hop Cochin, AP HP, Med Oncol, Paris, France
[8] CHU Pontchaillou, Orthoped Surg, Rennes, France
[9] ICO Inst Cancerol Ouest Rene Gauducheau, Med Oncol, St Herblain, France
[10] Inst Canc Montpellier, Med Oncol, Montpellier, France
[11] Ctr Georges Francois Leclerc Dijon, Dept Med Oncol, Dijon, France
[12] IUCT Oncopole Inst Claudius Regaud, Med Oncol, Toulouse, France
[13] CHU La Timone Adultes, Med Oncol, Marseille, France
[14] CHU Strasbourg, Nouvel Hop Civil, Med Oncol, Strasbourg, France
[15] Ctr Antoine Lacassagne, Med Oncol, Nice, France
[16] Ctr Henri Becquerel, Med Oncol, Rouen, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1689P
引用
收藏
页码:693 / 693
页数:1
相关论文
共 50 条
  • [1] Outcome of 91 clear cell sarcoma tumor patients: A retrospective study from the French Sarcoma Group (GSF-GETO).
    Firmin, Nelly
    Boudou-Rouquette, Pascaline
    Duliege, Delphine
    Chaltiel, Leonor
    Dumont, Sarah Naomie
    Toulmonde, Maud
    Salas, Sebastien
    Ray-Coquard, Isabelle Laure
    Valentin, Thibaud
    Piperno-Neumann, Sophie
    Ryckewaert, Thomas
    Bompas, Emmanuelle
    Isambert, Nicolas
    Kurtz, Jean-Emannuel
    Le Maignan, Christine
    Egea, Julie
    Bertucci, Francois
    Perrin, Christophe
    Larousserie, Frederique
    Chevreau, Christine
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Outcome of 157 adult rhabdomyosarcoma (RMS) patients: A retrospective study from the French Group Sarcoma (GSF-GETO).
    Bompas, E.
    Campion, L.
    Italiano, A.
    Cesne, A. L.
    Levra, M. Giaj
    Chevreau, C.
    Piperno-Neumann, S.
    Isambert, N.
    Thyss, A.
    Rios, M.
    Kurtz, J.
    Delcambre, C.
    Bay, J.
    Duffaud, F.
    Trassard, M.
    Soulie, P.
    Blay, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Outcome of 212 malignant phyllod tumor patents: A retrospective study from the French Sarcoma Group (GSF-GETO).
    Neron, Mathias
    Sajous, Christophe
    Neumann, Sophie Piperno
    Chakiba, Camille
    Ducoulombier, Agnes
    Owen, Clementine
    Salas, S. Bastien
    Bertucci, Francois
    Saada-Bouzid, Esma
    Valentin, Thibaud
    Bay, Jacques-Olivier
    Bompas, Emmanuelle
    Isambert, Nicolas
    Maran-Gonzalez, Aurelie
    Llacer, Carmen
    Carrere, Sebastien
    Cupissol, Didier
    Thezenas, Simon
    Blay, Jean-Yves
    Firmin, Nelly
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Adjuvant (A) and neoadjuvant (NeoA) chemotherapy (C) in resected synovial sarcoma (SS): A study of the French Sarcoma Group (GSF-GETO)
    Italiano, A.
    Dufresne, A.
    Bui, B. N.
    LeCesne, A.
    Blay, J. Y.
    Robin, Y.
    Coindre, J.
    Piperno-Neumann, S.
    Tubiana-Hulin, M.
    Penel, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] MANAGEMENT OF SOFT TISSUE SARCOMA (STS) IN FRANCE - A RETROSPECTIVE ANALYSIS OF THE FRENCH CLINICAL BIOLOGICAL SARCOMA DATABASE (GSF-GETO)
    Longin, J.
    VALUE IN HEALTH, 2015, 18 (07) : A693 - A693
  • [6] Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
    Valentin, T.
    Le Cesne, A.
    Ray-Coquard, I.
    Italiano, A.
    Decanter, G.
    Bompas, E.
    Isambert, N.
    Thariat, J.
    Linassier, C.
    Bertucci, F.
    Bay, J. O.
    Bellesoeur, A.
    Penel, N.
    Le Guellec, S.
    Filleron, T.
    Chevreau, C.
    EUROPEAN JOURNAL OF CANCER, 2016, 56 : 77 - 84
  • [7] Weekly paclitaxel in metastatic angiosarcoma. A FNCLCC French Sarcoma Group (GSF-GETO) phase II trial
    Penel, N.
    Nguyen, B. Bui
    Bay, J. O.
    Cupissol, D.
    Ray-Coquard, I.
    Piperno-Neumann, S.
    Kerbrat, P.
    Fournier, C.
    Mahier, C.
    Blay, J. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Assessment of resection margins in bone sarcoma treated by neoadjuvant chemotherapy: Literature review and guidelines of the bone group (GROUPOS) of the French sarcoma group and bone tumor study group (GSF-GETO/RESOS)
    Gomez-Brouchet, Anne
    Mascard, Eric
    Siegfried, Aurore
    de Pinieux, Gonzague
    Gaspar, Nathalie
    Bouvier, Corinne
    Aubert, Sebastien
    Marec-Berard, Perrine
    Piperno-Neumann, Sophie
    Marie, Beatrice
    Larousserie, Frederique
    Galant, Christine
    Fiorenza, Fabrice
    Anract, Philippe
    de Gauzy, Jerome Sales
    Gouin, Francois
    ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH, 2019, 105 (04) : 773 - 780
  • [9] Long survivors with brain metastases from sarcomas: A retrospective analysis from the French Sarcoma Group (GSF/GETO)
    Isambert, N.
    Domont, J.
    Sunyach, M. P.
    Moureau-Zabotto, L.
    Bompas, E.
    Piperno-Neumann, S.
    Penel, N.
    Alcindor, T.
    Guillemet, C.
    Chaigneau, L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S880 - S881
  • [10] Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF/GETO)
    Ray-Coquard, Isabelle
    Italiano, Antoine
    Bompas, Emmanuelle
    Le Cesne, Axel
    Robin, Yves-Marie
    Chevreau, Christine
    Bay, Jacques-Olivier
    Bousquet, Guilhem
    Piperno-Neumann, Sophie
    Isambert, Nicolas
    Lemaitre, Laurent
    Fournier, Charles
    Gauthier, Eric
    Collard, Olivier
    Cupissol, Didier
    Clisant, Stephanie
    Blay, Jean-Yves
    Penel, Nicolas
    ONCOLOGIST, 2012, 17 (02): : 260 - 266